Home › Diffuse Scleroderma › Michigan › Ann Arbor
Diffuse Scleroderma clinical trials in Ann Arbor, MI
7 studies for Diffuse Scleroderma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
RecruitingPhase 2
- Uni Of Michigan Health System, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- University of Michigan, Ann Arbor
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
- Nkarta Investigational Site, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
RecruitingPhase 2
- Galderma Investigational Site # 8743, Ann Arbor
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Recruiting
- University of Michigan, Ann Arbor
Diffuse Scleroderma trials in other cities
- New York City, NY8 studies
- Chicago, IL7 studies
- Los Angeles, CA6 studies
- Durham, NC6 studies
- Boston, MA5 studies
- Houston, TX5 studies
- Baltimore, MD5 studies
- Philadelphia, PA4 studies
- Kansas City, KS4 studies
- New Orleans, LA4 studies
- Pittsburgh, PA4 studies
- Charleston, SC3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Non-Small Cell Lung Cancer26 studies
- Breast Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.